The drug Cimzia, already being used for treating Crohn’s Disease, has now been approved to treat moderate to severe rheumatoid arthritis according to a press release from UCB, the Belgian drug company that makes it.
Rheumatoid arthritis is a chronic disease characterized by inflammation of the lining of the joints. It can lead to joint damage, resulting in chronic pain, stiffness, loss of function and disability.
The most commonly reported side effects of Cimzia, which is administered by injection, include headache, upper respiratory infections, urinary tract infections and rashes at the injection site.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment